For the quarter ending 2025-09-30, MAIA has $11,782,021 in assets. $11,740,351 in debts.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 10,891,736 | 10,144,522 | ||
| Prepaid expenses and other current assets | 780,515 | 816,260 | ||
| Australia research and development incentives receivable | 82,685 | 82,272 | ||
| Total current assets | 11,754,936 | 11,043,054 | ||
| Other assets | 27,085 | 2,800 | ||
| Total assets | 11,782,021 | 11,045,854 | ||
| Accounts payable | 3,175,641 | 1,723,163 | ||
| Accrued expenses | 6,818,803 | 3,320,789 | ||
| Total current liabilities | 9,994,444 | 5,043,952 | ||
| Warrant liability | 1,745,907 | 2,125,218 | ||
| Total liabilities | 11,740,351 | 7,169,170 | ||
| Common stock, 0.0001 par value, 150,000,000 shares and 70,000,000 shares authorized at september 30, 2025 and at december 31, 2024, respectively, 34,451,153 and 26,157,788 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 3,446 | 3,182 | ||
| Additional paid-in capital | 106,071,303 | 101,002,585 | ||
| Accumulated deficit | -106,002,244 | -97,099,055 | ||
| Accumulated other comprehensive loss | -30,835 | -30,028 | ||
| Total stockholders equity | 41,670 | 3,876,684 | ||
| Total liabilities and stockholders equity | 11,782,021 | 11,045,854 | ||
MAIA Biotechnology, Inc. (MAIA)
MAIA Biotechnology, Inc. (MAIA)